|AM Pharma||General Counsel & VP Business Development||United Kingdom|
Taking the right fork in the road: What are the criteria to choose between out-licensing vs. creating a company?
Laetitia has over 18 years’ experience in multiple sectors, including 14 in the pharmaceuticals and medical device industry. She joined AM-Pharma in April 2020 as General Counsel and VP Business Development.
Before joining AM-Pharma, Laetitia was at UCB as global Associate General Counsel BD, M&A and Antitrust. Prior to that, she was Legal Director, Emerging Markets EMEA, Central European Region and Benelux at Zoetis (Pfizer former animal health division) and has also led the EMEA legal department for the Abbott Vascular division at Abbott. She also held global positions at the Carlson Rezidor Hotel Group and at the automotive division (Wabco) at American Standard.
Laetitia holds a Master’s degree in International and Comparative Law from the Vrije Universiteit Brussel and is a qualified lawyer in both the UK and Belgium, with extensive international experience, regularly speaking at various legal conferences.